These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
23. Disparities in adjuvant treatment of high-grade endometrial cancer in the Medicare population. Corey L, Cote ML, Ruterbusch JJ, Vezina A, Winer I. Am J Obstet Gynecol; 2022 Apr; 226(4):541.e1-541.e13. PubMed ID: 34736911 [Abstract] [Full Text] [Related]
24. Black and Hispanic women are less likely than white women to receive guideline-concordant endometrial cancer treatment. Kaspers M, Llamocca E, Quick A, Dholakia J, Salani R, Felix AS. Am J Obstet Gynecol; 2020 Sep; 223(3):398.e1-398.e18. PubMed ID: 32142825 [Abstract] [Full Text] [Related]
25. Systematic pelvic lymphadenectomy vs. no lymphadenectomy in early-stage endometrial carcinoma: randomized clinical trial. Benedetti Panici P, Basile S, Maneschi F, Alberto Lissoni A, Signorelli M, Scambia G, Angioli R, Tateo S, Mangili G, Katsaros D, Garozzo G, Campagnutta E, Donadello N, Greggi S, Melpignano M, Raspagliesi F, Ragni N, Cormio G, Grassi R, Franchi M, Giannarelli D, Fossati R, Torri V, Amoroso M, Crocè C, Mangioni C. J Natl Cancer Inst; 2008 Dec 03; 100(23):1707-16. PubMed ID: 19033573 [Abstract] [Full Text] [Related]
26. Survival impact based on the thoroughness of pelvic lymphadenectomy in intermediate- or high-risk groups of endometrioid-type endometrial cancer: A multi-center retrospective cohort analysis. Kim TH, Kim HS, Kim TJ, Chang SJ, Kim DY, Ryu SY, Kim BG, Kim YT, Bae DS, Ryu HS, Nam JH. Gynecol Oncol; 2016 Jun 03; 141(3):440-446. PubMed ID: 27020700 [Abstract] [Full Text] [Related]
28. Adjuvant Pelvic Radiation Therapy±Vaginal Brachytherapy in Patients With High-risk Stage I or Stage II Uterine Papillary Serous, Clear Cell, and High-grade Endometrioid Carcinoma. Nagar H, Yan W, Parashar B, Nori D, Chao KS, Christos P, Gupta D, Holcomb K, Caputo T, Wernicke AG. Am J Clin Oncol; 2016 Aug 03; 39(4):335-9. PubMed ID: 27028349 [Abstract] [Full Text] [Related]
29. Prognosis for endometrial cancer patients treated with systematic pelvic and para-aortic lymphadenectomy followed by platinum-based chemotherapy. Sueoka K, Umayahara K, Abe A, Usami T, Yamamoto A, Nomura H, Matoda M, Okamoto S, Omatsu K, Kondo E, Kato K, Takeshima N. Int J Gynecol Cancer; 2015 Jan 03; 25(1):81-6. PubMed ID: 25347094 [Abstract] [Full Text] [Related]
32. Disparities in endometrial cancer outcomes between non-Hispanic White and Hispanic women. Rodriguez AM, Schmeler KM, Kuo YF. Gynecol Oncol; 2014 Dec 03; 135(3):525-33. PubMed ID: 25449307 [Abstract] [Full Text] [Related]
38. The complex triad of obesity, diabetes and race in Type I and II endometrial cancers: prevalence and prognostic significance. Ko EM, Walter P, Clark L, Jackson A, Franasiak J, Bolac C, Havrilesky L, Secord AA, Moore DT, Gehrig PA, Bae-Jump VL. Gynecol Oncol; 2014 Apr 03; 133(1):28-32. PubMed ID: 24680588 [Abstract] [Full Text] [Related]
39. Clinicopathological characteristics, treatment and outcomes in uterine carcinosarcoma and grade 3 endometrial cancer patients: a comparative study. Zhu J, Wen H, Bi R, Wu X. J Gynecol Oncol; 2016 Mar 03; 27(2):e18. PubMed ID: 26463439 [Abstract] [Full Text] [Related]